FindMyKOL
Clinical trialNCT00848250CompletedInterventional

Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children

SponsorVanderbilt University Medical CenterEnrollment21Congenital Heart Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether ACE inhibitors alter the fibrinolytic, inflammatory, and hemodynamic response to cardiopulmonary bypass in infants and children with congenital heart disease.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Gregory A Fleming, MD

    Vanderbilt University Medical Center, Division of Pediatric Cardiology

    Principal Investigator
  • Mias Pretorius, MBChB, MSCI

    Vanderbilt University Medical Center, Department of Anesthesiology

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Monroe Carell Jr. Children'S Hospital at Vanderbilt

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Angiotensin Converting Enzyme Inhibitor
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2008
Primary completion
31 Jul 2010
Completion
31 Jul 2010
Last update posted
26 Jul 2017
Registered enrollment
21
Registry id
NCT00848250

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.